Biotechnology
In this section you will find Biotechnology market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Practical Guide to Finding Partners
$995.00Published by CurrentPartnering on Feb 1st, 2012The report takes the reader through the practical steps required to prepare for partnering, prepare supporting materials, identify and shortlist potential partners and opportunities, identifying and contacting the right person... Learn More -
Booming Biotech Market in India
$800.00Published by RNCOS on Oct 1st, 2011Indian biotech sector is witnessing a quantum surge in terms of growth of the industry. The growth can be attributed to a large pool of scientific talent, world-class information... Learn More -
Global Biofuel Market Analysis
$1,600.00Published by RNCOS on Sep 1st, 2011The global biofuel industry has been witnessing rapid growth over the past few years in the backdrop of depleting fossil fuels and degradation of environmental conditions. Since the second half... Learn More -
Asia Pacific Biotechnology Market (2008-2012)
$1,600.00Published by RNCOS on Jun 1st, 2011The Asia Pacific biotechnology market is one with immense potential, which can be tapped through investments driving the infrastructure and R&D in the sector. Investments in the past have... Learn More -
Asia Pacific Biotechnology Market (2008-2012)
$1,600.00Published by RNCOS on Jun 1st, 2011The Asia Pacific biotechnology market is one with immense potential, which can be tapped through investments driving the infrastructure and R&D in the sector. Investments in the past have... Learn More -
Global Bioinformatics Market Outlook
Published by RNCOS on Mar 1st, 2011Regular Price: $1,000.00
Special Price: $600.00
Major countries of the world have always tried to build strategies that ensure better development of strong biotechnology sector and in this aim; bio-informatics has been playing a vital... Learn More -
Bristol-Myers Squibb Co.: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 17th, 2010This analysis examines the historical and forecast performance for Bristol-Myers Squibb in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of... Learn More -
Abbott Laboratories: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 16th, 2010This analysis examines the historical and forecast performance for Abbott in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance... Learn More -
Alcon Inc.: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 16th, 2010This analysis examines the historical and forecast performance for Alcon in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance... Learn More -
Daiichi Sankyo Co., Ltd: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 14th, 2010This analysis examines the historical and forecast performance for Daiichi Sankyo in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial... Learn More -
Watson Pharmaceuticals Inc.: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 13th, 2010This analysis examines the historical and forecast performance for Watson in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance... Learn More -
Cephalon Inc.: PharmaVitae Profile
$11,400.00Published by Datamonitor on Dec 10th, 2010This analysis examines the historical and forecast performance for Cephalon in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance... Learn More -
H. Lundbeck A/S: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 10th, 2010This analysis examines the historical and forecast performance for Lundbeck in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance... Learn More -
Celgene Corporation: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 9th, 2010This analysis examines the historical and forecast performance for Celgene in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance... Learn More -
Forest Laboratories Inc.: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 7th, 2010This analysis examines the historical and forecast performance for Forest in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance... Learn More
Biotechnology
In this section you will find Biotechnology market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Practical Guide to Finding Partners
$995.00Published by CurrentPartnering on Feb 1st, 2012The report takes the reader through the practical steps required to prepare for partnering, prepare supporting materials, identify and shortlist potential partners and opportunities, identifying and contacting the right person... Learn More -
Booming Biotech Market in India
$800.00Published by RNCOS on Oct 1st, 2011Indian biotech sector is witnessing a quantum surge in terms of growth of the industry. The growth can be attributed to a large pool of scientific talent, world-class information... Learn More -
Global Biofuel Market Analysis
$1,600.00Published by RNCOS on Sep 1st, 2011The global biofuel industry has been witnessing rapid growth over the past few years in the backdrop of depleting fossil fuels and degradation of environmental conditions. Since the second half... Learn More -
Asia Pacific Biotechnology Market (2008-2012)
$1,600.00Published by RNCOS on Jun 1st, 2011The Asia Pacific biotechnology market is one with immense potential, which can be tapped through investments driving the infrastructure and R&D in the sector. Investments in the past have... Learn More -
Asia Pacific Biotechnology Market (2008-2012)
$1,600.00Published by RNCOS on Jun 1st, 2011The Asia Pacific biotechnology market is one with immense potential, which can be tapped through investments driving the infrastructure and R&D in the sector. Investments in the past have... Learn More -
Global Bioinformatics Market Outlook
Published by RNCOS on Mar 1st, 2011Regular Price: $1,000.00
Special Price: $600.00
Major countries of the world have always tried to build strategies that ensure better development of strong biotechnology sector and in this aim; bio-informatics has been playing a vital... Learn More -
Bristol-Myers Squibb Co.: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 17th, 2010This analysis examines the historical and forecast performance for Bristol-Myers Squibb in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of... Learn More -
Abbott Laboratories: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 16th, 2010This analysis examines the historical and forecast performance for Abbott in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance... Learn More -
Alcon Inc.: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 16th, 2010This analysis examines the historical and forecast performance for Alcon in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance... Learn More -
Daiichi Sankyo Co., Ltd: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 14th, 2010This analysis examines the historical and forecast performance for Daiichi Sankyo in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial... Learn More -
Watson Pharmaceuticals Inc.: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 13th, 2010This analysis examines the historical and forecast performance for Watson in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance... Learn More -
Cephalon Inc.: PharmaVitae Profile
$11,400.00Published by Datamonitor on Dec 10th, 2010This analysis examines the historical and forecast performance for Cephalon in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance... Learn More -
H. Lundbeck A/S: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 10th, 2010This analysis examines the historical and forecast performance for Lundbeck in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance... Learn More -
Celgene Corporation: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 9th, 2010This analysis examines the historical and forecast performance for Celgene in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance... Learn More -
Forest Laboratories Inc.: PharmaVitae Profile
$5,700.00Published by Datamonitor on Dec 7th, 2010This analysis examines the historical and forecast performance for Forest in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance... Learn More